Progress 05/01/24 to 04/30/25
Outputs Target Audience:
Nothing Reported
Changes/Problems:Due to the unfortunate passing of Dr. Sullivan, we have fully transitioned his PI role on this project to Dr. Miren Atristain with the approval of our USDA NIFA program officer. What opportunities for training and professional development has the project provided?Multiple undergraduate and graduate (MS and PhD) students have had the opportunity to participate in this project as part of our field sampling teams on farms, in the rivers, and at the wastewater treatment plants. In addition, graduate students have been directly engaged in the laboratory and data analysis and reporting phases of the project. We expect to complete the training of graduate students involved in this project during this final no-cost extension year. How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Throughout this final no-cost extension year of the project, we expect to finalize the sequencing and characterization of isolates from agricultural facilities, the rivers, wastewater treatment plants, and wildlife populations as described in our original proposal. We expect to finalize our data analysis, and to fully summarize and report our results in peer-reviewed scientific manuscripts.
Impacts What was accomplished under these goals?
During 2024 we finalize the field sampling component of the project, including farm, wildlife, and environmental sampling. We have collected over 2500 individual field samples from a variety of sources including livestock, wildlife, river water, fish, and wastewater influent and effluent as described in the proposal. We recovered carbapenemase producing isolates from approximately 5% of the samples with the highest frequency of recovery from wastewater influent and fish sampled near wastewater effluent discharge. The majority of the recovered isolates represented the KPC carbapenemase genotype, but the NDM genotype appears to be becoming more common. We have also recovered carbapenemase producing isolates from livestock facilities, but these do not appear to be directly associated with wastewater discharge and environmental dissemination of healthcare associated strains. As we complete the final no-cost extension year of the project, we are now focused on characterization of isolates via sequencing, data analysis, and preparation of reports including scientific manuscripts.
Publications
|
Progress 05/01/23 to 04/30/24
Outputs Target Audience:
Nothing Reported
Changes/Problems:Due to the unfortunate passing of Dr. Sullivan, we have transitioned his PI role on this project toDr. Miren Atristain with the approval of our USDA program officer. What opportunities for training and professional development has the project provided?Multiple MS and PhD students have had the opportunity to participate in this project as part of our field sampling teams on farms, in the rivers, and at the wastewater treatment plants. We expect to continue to train graduate and undergraduate students as part of this project going forward. How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Throughout 2024we expect to finalizethe field samping at agricultural facilities, in the rivers, at wastewater treatment plants, and in wildlife populations as described in our original proposal. We expect to transition to finalizing the characterization of isolates and analyzing, summarizing, and reporting our results.
Impacts What was accomplished under these goals?
During 2023we made significant progress in finalizing the field sampling component of the project. We have collected over 1500 individual field samples from a variety of sources including livestock, wildlife, river water, fish, and wastewater influent and effluent as described in the proposal. We recovered carbapenemase producting isolates from approximately 5% of the samples with the highest frequency of recovery from wastewater influent and fish sampled near wastewater effluent discharge. The majority of the recovered isolates represented the KPC carbapenemase genotype, but the NDM genotype appears to be becoming more common. As we approach the final year of the project, we are transitioning from field sampling to isolate characterization and data analysis.
Publications
|
Progress 05/01/22 to 04/30/23
Outputs Target Audience:
Nothing Reported
Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?Multiple MS and PhD students have had the opportunity to participate in this project as part of our field sampling teams on farms, in the rivers, and at the wastewater treatment plants. We expect to continue to train graduate and undergraduate students as part of this project going forward. How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Throughout 2023we expect to continue our focus on the field samping at agricultural facilities, in the rivers, at wastewater treatment plants, and in wildlife populations as described in our original proposal. We have been somewhat delayed in our sampling due to earlier COVID lab shutdown, but we are now on track to complete field sampling in a timely manner that will allow us to fully meet the objectives of the study.
Impacts What was accomplished under these goals?
During 2022we made significant progress in the field sampling component of the project. We collected over1000 individual field samples from a variety of sources including livestock, wildlife, river water, fish, and wastewater influent and effluent as described in the proposal. We recovered carbapenemase producting isolates from approximately 5% of the samples with the highest frequency of recovery from wastewater influent and fish sampled near wastewater effluent discharge. The majority of the recovered isolates represented the KPC carbapenemase genotype. Additional field sampling as described in the original proposal will continure through 2023.
Publications
|
Progress 05/01/21 to 04/30/22
Outputs Target Audience:
Nothing Reported
Changes/Problems:Since we are now past the earlier COVID limitations on research, we can now make appropriate progress on the project to fully meet our objectives. What opportunities for training and professional development has the project provided?Multiple MS and PhD students have had the opportunity to participate in this project as part of our field sampling teams on farms, in the rivers, and at the wastewater treatment plants. Weexpect to continue to train graduate and undergraduate students as part of this project going forward. How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?Throughout2022 we expect to continue our focus on the field samping at agricultural facilities, in the rivers, at wastewater treatment plants, and in wildlife populations as described in our original proposal. We have been somewhat delayed in our sampling due to earlier COVID lab shutdown, but we are now on track to complete field sampling in a timely manner that will allow us to fully meet the objectives of the study.
Impacts What was accomplished under these goals?
During 2021 we made significant progress in the field sampling component of the project. We collected approximately 1500 individual field samples from a variety of sources including livestock, wildlife, river water, fish, and wastewater influent and effluent as described in the proposal. Werecovered carbapenemase producting isolates from approximately 6% of the samples with the highest frequency of recovery from wastewater influent and fish sampled near wastewater effluent discharge. The majority of the recovered isolates represented the KPC carbapenemase genotype. Additional field sampling as described in the original proposal will continure through 2022.
Publications
|
Progress 05/01/20 to 04/30/21
Outputs Target Audience:
Nothing Reported
Changes/Problems:The major problem was the COVID-19 shutdown of all university laboratories which required us to pospone the initiation of this project. However, we expect to be able to complete all objectives on a somewhat delayed timeline. What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period we expect to initiate our field sampling plan as described in the proposal.
Impacts What was accomplished under these goals?
Due to the COVID-19 shutdown of our laboaratories during 2020, our field sampling was postponed until 2021.
Publications
|
|